S&P 500
(0.10%) 5 253.52 points
Dow J
(0.01%) 39 763 points
Nasdaq
(0.01%) 16 401 points
Oil
(1.59%) $82.64
Gas
(0.52%) $1.727
Gold
(0.96%) $2 233.90
Silver
(0.89%) $24.97
Platinum
(1.52%) $923.55
USD/EUR
(0.24%) $0.926
USD/NOK
(0.48%) $10.82
USD/GBP
(0.01%) $0.791
USD/RUB
(0.26%) $92.68

Realtime updates for Global Blood [GBT]

Exchange: NASDAQ Global Select Sector: Healthcare Industry: Biotechnology
Last Updated4 Oct 2022 @ 16:00

0.01% $ 68.49

Live Chart Being Loaded With Signals

Commentary (4 Oct 2022 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD)...

Stats
Today's Volume 3.28M
Average Volume 0
Market Cap 0.00
EPS $0 ( 2022-11-02 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -14.08
ATR14 $0.890 (1.30%)
Insider Trading
Date Person Action Amount type
2022-10-05 Perry Mark L Sell 5 600 Stock Option (Right to Buy)
2022-10-05 Patrick Deval L Sell 5 600 Stock Option (Right to Buy)
2022-10-05 Morrison Scott W Sell 5 600 Stock Option (Right to Buy)
2022-10-05 Thompson Alexis A. Sell 3 600 Restricted Stock Units
2022-10-05 Yarno Wendy L Sell 30 000 Stock Option (Right to Buy)
INSIDER POWER
-60.12
Last 100 transactions
Buy: 278 284 | Sell: 1 075 911

Volume Correlation

Long: 0.35 (neutral)
Short: 0.93 (very strong)
Signal:(77.112) Expect same movement, but be aware

Global Blood Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Global Blood Correlation - Currency/Commodity

The country flag 0.26
( neutral )
The country flag -0.10
( neutral )
The country flag 0.47
( neutral )
The country flag 0.56
( weak )
The country flag -0.62
( weak negative )
The country flag -0.83
( strong negative )

Global Blood Financials

Annual 2021
Revenue: $194.75M
Gross Profit: $191.43M (98.30 %)
EPS: $-4.82
Q2 2022
Revenue: $71.55M
Gross Profit: $70.14M (98.03 %)
EPS: $-1.260
Q1 2022
Revenue: $55.16M
Gross Profit: $54.11M (98.09 %)
EPS: $-1.260
Q4 2021
Revenue: $56.10M
Gross Profit: $54.95M (97.94 %)
EPS: $-1.360

Financial Reports:

No articles found.

Global Blood

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators